Unknown

Dataset Information

Current opinion and mechanistic interpretation of combination therapy for castration-resistant prostate cancer.


ABSTRACT: Recent advances in genomics technology have led to the massive discovery of new drug targets for prostate cancer; however, none of the currently available therapeutics is curative. One of the greatest challenges is drug resistance. Combinations of therapies with distinct mechanisms of action represent a promising strategy that has received renewed attention in recent years. Combination therapies exert cancer killing functions through either concomitant targeting of multiple pro-cancer factors or more effective inhibition of a single pathway. Theoretically, the combination therapy can improve efficacy and efficiency compared with monotherapy. Although increasing numbers of drug combinations are currently being tested in clinical trials, the mechanisms by which these combinations can overcom

SUBMITTER: Xu J 

PROVIDER: S-EPMC6498727 | biostudies-literature | 2019 May-Jun

REPOSITORIES: biostudies-literature